SNDX SCHEDULE 13G: SEC filing
State Street Corporation
Filed with the SEC on · accession 0000093751-26-000728
SNDX filed a SCHEDULE 13G (schedule 13g) with the SEC on Nov 10, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
State Street Corporation filed a Schedule 13G disclosing a passive 5.2% ownership stake in Syndax Pharmaceuticals Inc, holding approximately 4,653,172 shares as of September 30, 2026.
Key details
✦ Ask GOAX AI about this filing — what it means for SNDX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SNDX?
Click hereFrequently asked questions
What did SNDX file with the SEC on Nov 10, 2026?
SNDX filed a SCHEDULE 13G (SEC filing). State Street Corporation filed a Schedule 13G disclosing a passive 5.2% ownership stake in Syndax Pharmaceuticals Inc, holding approximately 4,653,172 shares as of September 30, 2026.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
Other SNDX SEC filings
- 10-Q · SEC filingNov 2, 2026
- 8-K · SEC filingNov 2, 2026
- 8-K · SEC filingAug 4, 2026
- 10-Q · SEC filingAug 4, 2026
- 8-K · SEC filingJul 14, 2026
- 144 · Insider sale plannedJul 8, 2026
- 144 · Insider sale plannedJun 12, 2026
- 144 · Insider sale plannedJun 11, 2026
- 8-K · SEC filingJun 10, 2026
- 8-K · Material agreementJun 10, 2026
Get alerts when SNDX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days